SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-011483
Filing Date
2022-06-10
Accepted
2022-06-10 16:15:14
Documents
12
Period of Report
2022-06-08
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K nktx-20220608.htm   iXBRL 8-K 68962
  Complete submission text file 0000950170-22-011483.txt   197319

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nktx-20220608.xsd EX-101.SCH 2488
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nktx-20220608_pre.xml EX-101.PRE 11594
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nktx-20220608_lab.xml EX-101.LAB 18598
6 EXTRACTED XBRL INSTANCE DOCUMENT nktx-20220608_htm.xml XML 4889
Mailing Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080
Business Address 6000 SHORELINE COURT SUITE 102 SOUTH SAN FRANCISCO CA 94080 415-582-4923
Nkarta, Inc. (Filer) CIK: 0001787400 (see all company filings)

IRS No.: 474515206 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39370 | Film No.: 221009048
SIC: 2834 Pharmaceutical Preparations